Skip to content

A prospective study of cognitive function outcomes after ischemic stroke

A prospective study of cognitive function outcomes after ischemic stroke

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053573
Enrollment
Unknown
Registered
2021-11-24
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

case series:none

Sponsors

Provincial Hospital Affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. The admission diagnosis was the first acute cerebral infarction (confirmed by CT or MR).

Exclusion criteria

Exclusion criteria: 1. Past history of dementia. 2. This NIHSS score is greater than or equal to 15 points. 3. There are other neurological diseases that can cause brain dysfunction (such as depression, brain tumor, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, brain trauma, normal intracranial pressure hydrocephalus, etc.). 4. Other systemic diseases with unstable vital signs or cognitive impairment: liver and renal insufficiency, rheumatoid arthritis (abnormal serum inflammatory markers), abnormal thyroid function, severe anemia, folic acid and vitamin B12 deficiency, specific infections (eg, syphilis, HIV), alcohol and drug abuse, others (to be discussed with the team). 5. There is mental and neurodevelopmental delay. 6. The presence of other diseases known to cause cognitive impairment. 7. Severe heart and lung diseases (myocardial infarction, heart failure, hypertrophic cardiomyopathy). 8. There are contraindications to MRI. 9. Suffering from diseases that cannot cooperate with the completion of cognitive examinations (aphasia, hand paralysis (muscle strength less than grade 3). 10. Refusing to draw blood. 11. Refused to sign the informed consent during the baseline period.

Design outcomes

Primary

MeasureTime frame
Cognitive function;Alanine aminotransferase;Total protein;Albumin;Direct bilirubin;Total bilirubin;Total cholesterol;Triglycerides;Homocysteine;Creatinine;Urea;Uric acid;C reactive protein;Vitamin B12;Folic acid;Troponin T;Free triiodothyronine;Free thyroxine;Thyroid stimulating hormone;Human immunodeficiency virus antigen antibody;Syphilis spiral antibody;Prothrombin time;Activated partial thromboplastin time;D-dimer;Creatine kinase isoenzyme;Myoglobin;Brain natriuretic peptide;High-sensitivity troponin T;

Countries

China

Contacts

Public ContactWang Xiang

Provincial Hospital Affiliated to Shandong First Medical University

higherwx@163.com+86 13953151360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026